Art Kaufman To Join Manhattan Scientifics Science And Technology Committee

Joins Martin Cooper 'Father Of The Cell Phone'

April 8, 2008

Click here to view the printer friendly version of this press release


LOS ALAMOS, N.M., April 08, 2008--Manhattan Scientifics (MHTX:PK) announced today that Dr. Art Kaufman has joined it’s Science and Technology Committee, whose members include Martin Cooper, father of modern wireless communications, Donald J. Sandstrom, former MST Division Leader at the Los Alamos National Laboratory and Terry C. Lowe, former CEO of Technanogy Inc., the world's first and largest nanotechnology incubator.

Dr. Kaufman was a co-founder of H-Power, a leading company in the hydrogen fuel cell industry. He holds a B.S., M.S., and Ph.D. in chemical engineering from MIT, the University of Florida, and the University of Connecticut.He holds the Distinguished Engineering Alumni Award from the University of Connecticut.

Manny Tsoupanarias CEO of Manhattan Scientifics, added, "The addition of Dr. Kaufman will greatly enhance our ability to investigate and validate any new or present initiatives in the alternative energy sector.”

About Manhattan Scientifics

Manhattan Scientifics, Inc. ( is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.

Forward-looking statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.